Methotrexate and Laryngeal stenosis - a phase IV clinical study of FDA data
Summary:
Laryngeal stenosis is reported as a side effect among people who take Methotrexate (methotrexate sodium), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Prednisone, and have Angiocentric lymphoma.
The phase IV clinical study analyzes which people have Laryngeal stenosis when taking Methotrexate. It is created by eHealthMe based on reports of 599,650 people who have side effects when taking Methotrexate from the FDA, and is updated regularly.
What is Methotrexate?
Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,313 Methotrexate users. Check the latest studies of Methotrexate.
What is Laryngeal stenosis?
Laryngeal stenosis (narrowing of larynx) is found to be associated with 107 drugs and 148 conditions by eHealthMe. Check the latest studies of Laryngeal stenosis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
599,650 people reported to have side effects when taking Methotrexate.
Among them, 68 people (0.01%) have Laryngeal stenosis.

Among these 68 people:
How long have people been on Methotrexate when they have Laryngeal stenosis? *
- < 1 month: 0.0 %
- 1 - 6 months: 33.33 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 33.33 %
- 2 - 5 years: 33.33 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Laryngeal stenosis when taking Methotrexate? *
- female: 94.55 %
- male: 5.45 %
What is the age of people who have Laryngeal stenosis when taking Methotrexate? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 8.7 %
- 20-29: 8.7 %
- 30-39: 26.09 %
- 40-49: 21.74 %
- 50-59: 30.43 %
- 60+: 4.35 %
What are other drugs people take besides Methotrexate? *
- Prednisone: 26 people, 38.24%
- Folic Acid: 20 people, 29.41%
- Cyclobenzaprine Hydrochloride: 11 people, 16.18%
- Diclofenac Sodium: 11 people, 16.18%
- Depo-Medrol: 11 people, 16.18%
- Calcium: 10 people, 14.71%
- Cyanocobalamin: 7 people, 10.29%
- Septra: 7 people, 10.29%
- Methylprednisolone: 5 people, 7.35%
- Vitamin D: 5 people, 7.35%
What are other side effects people have besides Laryngeal stenosis? *
- Dyspnea (difficult or laboured breathing): 20 people, 29.41%
- Drug Ineffective: 15 people, 22.06%
- Haematuria (presence of blood in urine): 14 people, 20.59%
- Infection: 13 people, 19.12%
- Pulmonary Mass: 11 people, 16.18%
- Bronchial Wall Thickening: 11 people, 16.18%
- High Blood Pressure: 11 people, 16.18%
- Liver Disorder (liver diseases): 11 people, 16.18%
- Pulmonary Cavitation (cavity in the lung): 10 people, 14.71%
- Nosebleed (bleeding from nose): 10 people, 14.71%
What are the existing conditions these people have? *
- Vasculitis (inflammation of a blood vessel or blood vessels): 2 people, 2.94%
- Psoriasis (immune-mediated disease that affects the skin): 2 people, 2.94%
- Angiocentric Lymphoma (extra nodal natural killer cell cancer): 2 people, 2.94%
- Wegener's Granulomatosis (inflammation of the blood vessels lungs sinuses): 1 person, 1.47%
- Polychondritis (progressive inflammation of cartilage and other connective tissue): 1 person, 1.47%
- Microscopic Polyangiitis (inflammation involving multiple blood or lymph small-vessel): 1 person, 1.47%
- Hypersensitivity: 1 person, 1.47%
- High Blood Pressure: 1 person, 1.47%
- Headache (pain in head): 1 person, 1.47%
- Cardiac Disorder: 1 person, 1.47%
* Approximation only. Some reports may have incomplete information.
Do you take Methotrexate and have Laryngeal stenosis?
- Check whether Laryngeal stenosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Methotrexate:
- Methotrexate (604,313 reports)
Laryngeal stenosis treatments and more:
- Laryngeal stenosis (808 reports)
How severe was Laryngeal stenosis and when was it recovered:
Expand to all the drugs that have ingredients of methotrexate sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methotrexate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Laryngeal stenosis:
- Laryngeal stenosis (107 drugs)
Browse all the conditions that are associated with Laryngeal stenosis:
- Laryngeal stenosis (148 conditions)
Related publications that referenced our studies
- Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .
- Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on methotrexate sodium (the active ingredients of Methotrexate) and Methotrexate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Chronic Kidney Disease and Hyperkalemia - 13 seconds ago
- Zoledronic Acid and Silver drug interactions for women aged 60+ - 17 seconds ago
- Could Centrum Silver cause Proctalgia? - 27 seconds ago
- Could Vitamin C cause Oxygen Consumption Decreased? - a minute ago
- Hot Flush and Hypersensitivity - a minute ago
- Could Carfilzomib cause Visual Acuity Reduced? - a minute ago
- Could Magnesium Oxide cause Road Traffic Accident? - a minute ago
- Could Imbruvica cause Respiratory Tract Congestion? - a minute ago
- Heart Palpitations in Aripiprazole, how severe and when it was recovered? - a minute ago
- Ceftriaxone and Wide-Complex Tachycardia for Women aged 60+ - a minute ago